These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 38089042)

  • 1. Multi-dimensional role of gangliosides in modulating cancer hallmarks and their prospects in targeted cancer therapy.
    Sarkar A; Banerjee S; Biswas K
    Front Pharmacol; 2023; 14():1282572. PubMed ID: 38089042
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Cavdarli S; Delannoy P; Groux-Degroote S
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192217
    [No Abstract]   [Full Text] [Related]  

  • 3. Gangliosides as Signaling Regulators in Cancer.
    Sasaki N; Toyoda M; Ishiwata T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of brain ganglioside acetylation patterns in mice with altered ganglioside biosynthesis.
    Mlinac K; Fabris D; Vukelić Z; Rožman M; Heffer M; Bognar SK
    Carbohydr Res; 2013 Dec; 382():1-8. PubMed ID: 24140892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response.
    Yang J; Han L; Sha Y; Jin Y; Li Z; Gong B; Li J; Liu Y; Wang Y; Zhao Q
    Front Immunol; 2022; 13():1061814. PubMed ID: 36605200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of
    Cavdarli S; Yamakawa N; Clarisse C; Aoki K; Brysbaert G; Le Doussal JM; Delannoy P; Guérardel Y; Groux-Degroote S
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues.
    Bernhard H; Roth S; Bauerschmitz J; Meyer zum Büschenfelde KH; Dippold W
    Int J Cancer; 1992 Jun; 51(4):568-72. PubMed ID: 1376299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment.
    van der Haar Àvila I; Windhouwer B; van Vliet SJ
    Cancer Metastasis Rev; 2023 Sep; 42(3):941-958. PubMed ID: 37266839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gangliosides as therapeutic targets for cancer.
    Fredman P; Hedberg K; Brezicka T
    BioDrugs; 2003; 17(3):155-67. PubMed ID: 12749752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganglioside as a Therapy Target in Various Types of Cancer.
    Qamsari ES; Nourazarian A; Bagheri S; Motallebnezhad M
    Asian Pac J Cancer Prev; 2016; 17(4):1643-7. PubMed ID: 27221833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
    Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
    J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Control of Ganglioside Expression in Mammalian Tissues.
    Okuda T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31887977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting
    Fleurence J; Fougeray S; Bahri M; Cochonneau D; Clémenceau B; Paris F; Heczey A; Birklé S
    J Immunol Res; 2017; 2017():5604891. PubMed ID: 28154831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition.
    Fazzari M; Lunghi G; Chiricozzi E; Mauri L; Sonnino S
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside enhancement of neuronal differentiation, plasticity, and repair.
    Gorio A
    CRC Crit Rev Clin Neurobiol; 1986; 2(3):241-96. PubMed ID: 3536311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gangliosides and autoimmune diabetes.
    Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
    Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics.
    Hegde M; Girisa S; Aswani BS; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Life Sci; 2024 Aug; 351():122786. PubMed ID: 38848944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells.
    Sjoberg ER; Manzi AE; Khoo KH; Dell A; Varki A
    J Biol Chem; 1992 Aug; 267(23):16200-11. PubMed ID: 1644805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the localization of gangliosides using anti-ganglioside antibodies: comparison of fixation methods.
    Schwarz A; Futerman AH
    J Histochem Cytochem; 1997 Apr; 45(4):611-8. PubMed ID: 9111239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.